← Back to Search
Surface α-Enolase Promotes Extracellular Matrix Degradation And Tumor Metastasis And Represents A New Therapeutic Target
Kuan-Chung Hsiao, N. Shih, Hsun-Lang Fang, T. Huang, Ching-Chuan Kuo, P. Chu, Yi-Mei Hung, S. Chou, Yi-yuan Yang, G. Chang, K. Liu
Published 2013 · Biology, Medicine
Download PDFAnalyze on Scholarcy
In previous research, we found α-enolase to be inversely correlated with progression-free and overall survival in lung cancer patients and detected α-enolase on the surface of lung cancer cells. Based on these findings, we hypothesized that surface α-enolase has a significant role in cancer metastasis and tested this hypothesis in the current study. We found that α-enolase was co-immunoprecipitated with urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen in lung cancer cells and interacted with these proteins in a cell-free dot blotting assay, which can be interrupted by α-enolase-specific antibody. α-Enolase in lung cancer cells co-localized with these proteins and was present at the site of pericellular degradation of extracellular matrix components. Treatment with antibody against α-enolase in vitro suppressed cell-associated plasminogen and matrix metalloproteinase activation, collagen and gelatin degradation, and cell invasion. Examination of the effect of treatment with shRNA plasmids revealed that down regulation of α-enolase decreases extracellular matrix degradation by and the invasion capacity of lung cancer cells. Adoptive transfer of α-enolase-specific antibody to mice resulted in accumulation of antibody in subcutaneous tumor and inhibited the formation of tumor metastasis in lung and bone. This study demonstrated that surface α-enolase promotes extracellular matrix degradation and invasion of cancer cells and that targeting surface α-enolase is a promising approach to suppress tumor metastasis.
This paper references
Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer.
P. Cozzi (2006)
Inhibiting citrullination in rheumatoid arthritis: taking fuel from the fire
B. Fisher (2012)
Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.
N. Shih (2010)
Urokinase-type plasminogen activator system and breast cancer (Review).
B. Han (2005)
Human Metastatic Prostate PC3 Cell Lines Degrade Bone Using Matrix Metalloproteinases
O. Sanchezsweatman (1998)
Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α‐Enolase
R. López-Alemany (2003)
Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis
Natalia Wegner (2010)
Generation and characterization of anti-α-enolase single-chain antibodies in chicken
S. Leu (2010)
The Plasminogen Activator System and Cancer
Brandon J. McMahon (2007)
Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice
D. Jenkins (2004)
The Role of Annexin A2 in Tumorigenesis and Cancer Progression
N. Lokman (2011)
Liver metastasis at the time of initial diagnosis of lung cancer
K. Kagohashi (2003)
Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells.
Xiaodong Tan (2006)
Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy.
Rohit G. Saldanha (2007)
Metastasis: from dissemination to organ-specific colonization
D. Nguyen (2009)
Streptococcus pneumoniae enolase is important for plasminogen binding despite low abundance of enolase protein on the bacterial cell surface.
J. Kolberg (2006)
An integrated humoral and cellular response is elicited in pancreatic cancer by α‐enolase, a novel pancreatic ductal adenocarcinoma‐associated antigen
P. Cappello (2009)
MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2
O. Mendes (2007)
Direct observation of individual endogenous protein complexes in situ by proximity ligation
O. Söderberg (2006)
Cysteine cathepsins: multifunctional enzymes in cancer
M. Mohamed (2006)
Strategies for MMP inhibition in cancer: innovations for the post-trial era
C. Overall (2002)
Surface ENO1 Promotes Tumor Metastasis PLOS ONE | www.plosone
[Tumor metastasis and MMP inhibitor].
H. Sato (2006)
α‐enolase: a promising therapeutic and diagnostic tumor target
Michela Capello (2011)
Proteomics‐based identification of α‐enolase as a tumor antigen in non‐small lung cancer
P. He (2007)
Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis.
V. Saulot (2002)
Adrenal tumor volume in a genetically engineered mouse model of neuroblastoma determined by magnetic resonance imaging.
K. Kawano (2012)
Neurological diseases: Mechanisms, challenges and opportunities in stroke
E. Lo (2003)
Proteomic analysis of isolated membrane fractions from superinvasive cancer cells.
P. Dowling (2007)
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
P. Carmeliet (1997)
Multifunctional α-enolase: its role in diseases
V. Pancholi (2001)
Direct photometric or fluorometric assay of proteinases using substrates containing 7-amino-4-trifluoromethylcoumarin.
R. E. Smith (1980)
Prevention and Management of Bone Metastases in Lung Cancer: A Review
Hamed Al Husaini (2009)
2012) alpha-Enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritis
Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung.
M. Wygrecka (2009)
Exploitation of Astrocytes by Glioma Cells to Facilitate Invasiveness: A Mechanism Involving Matrix Metalloproteinase-2 and the Urokinase-Type Plasminogen Activator–Plasmin Cascade
D. Le (2003)
Immunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian α-enolase and arthritis in DR4-IE-transgenic mice.
Andrew J Kinloch (2011)
ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction.
S. Tsai (2010)
Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer.
P. He (2007)
Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone
S. Sone (2007)
Multifunctional alpha-enolase: its role in diseases.
V. Pancholi (2001)
Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitro
A. Schayowitz (2008)
Global cancer statistics
A. Jemal (2011)
The Role of Enolase in Tissue Invasion and Metastasis of Pathogens and Tumor Cells
K. Liu (2007)
α-Enolase Expressed on the Surfaces of Monocytes and Macrophages Induces Robust Synovial Inflammation in Rheumatoid Arthritis
S. Bae (2012)
Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes
G. Chang (2006)
Identification of a unique set of genes altered during cell-cell contact in an in vitro model of prostate cancer bone metastasis.
J. Wang (2006)
α-Enolase, a Multifunctional Protein: Its Role on Pathophysiological Situations
Á. Díaz-Ramos (2012)
The role of an enolase-related molecule in plasminogen binding to cells.
A. Redlitz (1995)
Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes Sl/Sld and W/Wv).
F. Arguello (1992)
Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancer.
Barbara Tomaino (2011)
Diagnostic detection of human lung cancer-associated antigen using a gold nanoparticle-based electrochemical immunosensor.
J. Ho (2010)
Control of type IV collagenase activity by components of the urokinase–plasmin system: a regulatory mechanism with cell‐bound reactants
R. Mazzieri (1997)
Glycolytic enzyme interactions with tubulin and microtubules.
J. Walsh (1989)
The plasminogen activation system in tumor growth, invasion, and metastasis
P. Andreasen (2000)
The urokinase receptor as a potential target in cancer therapy.
J. Romer (2004)
Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
P. Choong (2003)
This paper is referenced by
Biomechanical, ultrastructural, and electrophysiological characterization of the non-human primate experimental glaucoma model
VijayKrishna Raghunathan (2017)
Valor diagnóstico da expressão de α-enolase e dos níveis séricos de autoanticorpos contra α-enolase no câncer de pulmão
L. Zhang (2018)
In silico prediction of a new lead compound targeting enolase of trypanosomatids through structure-based virtual screening and molecular dynamic studies
V. Vidhya (2020)
Extracellular matrix degradation via enolase/plasminogen interaction: Evidence for a mechanism conserved in Metazoa
G. Grossi (2016)
Modulation of α-Enolase Post-Translational Modifications by Dengue Virus: Increased Secretion of the Basic Isoforms in Infected Hepatic Cells
L. Higa (2014)
Pro-invasive stimuli and the interacting protein Hsp70 favour the route of alpha-enolase to the cell surface
Giovanni Perconti (2017)
Elevated Glucose Levels Preserve Glucose Uptake, Hyaluronan Production, and Low Glutamate Release Following Interleukin-1β Stimulation of Differentiated Chondrocytes
V. Rotter Sopasakis (2018)
Hyperglycemia promotes Snail-induced epithelial–mesenchymal transition of gastric cancer via activating ENO1 expression
X. Xu (2019)
Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest
Michela Capello (2016)
Alpha-enolase ( ENO 1 ) controls alpha v / beta 3 integrin expression and regulates pancreatic cancer adhesion , invasion , and metastasis
M. Principe (2017)
From Plasminogen to Plasmin: Role of Plasminogen Receptors in Human Cancer
Miroslava Didiášová (2014)
Tumor Microenvironment: Extracellular Matrix Components – Part A
A. Birbrair (2020)
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis
M. Principe (2017)
Molecular characterization of a Trichinella spiralis enolase and its interaction with the host’s plasminogen
Peng Jiang (2019)
Deciphering the Role of Emx1 in Neurogenesis: A Neuroproteomics Approach
F. Kobeissy (2016)
ENO1‐targeted superparamagnetic iron oxide nanoparticles for detecting pancreatic cancer by magnetic resonance imaging
L. Wang (2020)
Syrosingopine sensitizes cancer cells to killing by metformin
D. Benjamin (2016)
Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system
Rubí Viedma-Rodríguez (2017)
CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1
J. Zhou (2019)
Placental proteome alterations in women with intrahepatic cholestasis of pregnancy
P. He (2014)
Epigenetic silence of lumican inhibits the motility of colon cancer via inactivating MAPK signaling in vitro and in vivo
F. Quan (2017)
Diagnostic value of α-enolase expression and serum α-enolase autoantibody levels in lung cancer
L. Zhang (2018)
Metabolic reprogramming in transformed mouse cortical astrocytes: A proteomic study.
Azéddine Bentaib (2015)
An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma
Grasieli de Oliveira (2020)
Putative salivary biomarkers useful to differentiate patients with fibromyalgia.
F. Ciregia (2019)
COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer
B. Hofmann (2015)
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells
M. Principe (2015)
Effects of RNA interference of the eno 1 gene on the malignant biological behaviors of gastric cell lines
T. Chen (2017)
Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor survival
H. Qiao (2019)
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
Niaz Mahmood (2018)
Experimental and bioinformatic approach to identifying antigenic epitopes in human α- and β-enolases
J. Pietkiewicz (2018)
Supplemental Information CD 95 / Fas Increases Stemness in Cancer Cells by Inducing a STAT 1-Dependent Type I Interferon Response
Abdul S Qadir (2017)See more